185 related articles for article (PubMed ID: 35915245)
21. Androgen receptor suppresses prostate cancer metastasis but promotes bladder cancer metastasis via differentially altering miRNA525-5p/SLPI-mediated vasculogenic mimicry formation.
Yang Z; Chen J; Xie H; Liu T; Chen Y; Ma Z; Pei X; Yang W; Li L
Cancer Lett; 2020 Mar; 473():118-129. PubMed ID: 31843555
[TBL] [Abstract][Full Text] [Related]
22. Hypoxia-induced shedding of MICA and HIF1A-mediated immune escape of pancreatic cancer cells from NK cells: role of circ_0000977/miR-153 axis.
Ou ZL; Luo Z; Wei W; Liang S; Gao TL; Lu YB
RNA Biol; 2019 Nov; 16(11):1592-1603. PubMed ID: 31402756
[TBL] [Abstract][Full Text] [Related]
23. Immunomodulatory functions of the circ_001678/miRNA-326/ZEB1 axis in non-small cell lung cancer via the regulation of PD-1/PD-L1 pathway.
Tian Q; Wu T; Zhang X; Xu K; Yin X; Wang X; Shi S; Wang P; Gao L; Xu S; Liu X
Hum Mol Genet; 2022 Nov; 31(23):4094-4106. PubMed ID: 35848890
[TBL] [Abstract][Full Text] [Related]
24. High dose androgen suppresses natural killer cytotoxicity of castration-resistant prostate cancer cells via altering AR/circFKBP5/miRNA-513a-5p/PD-L1 signals.
Tang M; Sun Y; Huang CP; Chen L; Liu B; You B; Wang Z; Chang C
Cell Death Dis; 2022 Aug; 13(8):746. PubMed ID: 36038573
[TBL] [Abstract][Full Text] [Related]
25. Lysine N-methyltransferase SETD7 promotes bladder cancer progression and immune escape via STAT3/PD-L1 cascade.
Lv J; Wu Q; Li K; Bai K; Yu H; Zhuang J; Sun H; Yang H; Yang X; Lu Q
Int J Biol Sci; 2023; 19(12):3744-3761. PubMed ID: 37564199
[No Abstract] [Full Text] [Related]
26. HNRNPL induced circFAM13B increased bladder cancer immunotherapy sensitivity via inhibiting glycolysis through IGF2BP1/PKM2 pathway.
Lv J; Li K; Yu H; Han J; Zhuang J; Yu R; Cheng Y; Song Q; Bai K; Cao Q; Yang H; Yang X; Lu Q
J Exp Clin Cancer Res; 2023 Feb; 42(1):41. PubMed ID: 36747239
[TBL] [Abstract][Full Text] [Related]
27. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma.
Jiang G; Shi L; Zheng X; Zhang X; Wu K; Liu B; Yan P; Liang X; Yu T; Wang Y; Cai X
Aging (Albany NY); 2020 Jun; 12(12):11466-11484. PubMed ID: 32579541
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
Roshani Asl E; Rasmi Y; Baradaran B
J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
[TBL] [Abstract][Full Text] [Related]
29. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
[No Abstract] [Full Text] [Related]
30. Circ_0002623 promotes bladder cancer progression by regulating the miR-1276/SMAD2 axis.
Zhang Z; Zhao H; Zhou G; Han R; Sun Z; Zhong M; Jiang X
Cancer Sci; 2022 Apr; 113(4):1250-1263. PubMed ID: 35048477
[TBL] [Abstract][Full Text] [Related]
31. Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling.
Chen J; Chou F; Yeh S; Ou Z; Shyr C; Huang C; Xiang Z; Sun Y; Messing E; Zu X; Chang C
Oncogene; 2020 Jan; 39(3):574-586. PubMed ID: 31506605
[TBL] [Abstract][Full Text] [Related]
32. Circular RNA_0000326 promotes bladder cancer progression via microRNA-338-3p/ETS Proto-Oncogene 1/phosphoinositide-3 kinase/Akt pathway.
Chen Y; Wang D; Shu T; Sun K; Zhao J; Wang M; Huang Y; Wang P; Zheng H; Cai Z; Yang Z
Bioengineered; 2021 Dec; 12(2):11410-11422. PubMed ID: 34889689
[TBL] [Abstract][Full Text] [Related]
33. LIN28/
Chen Y; Xie C; Zheng X; Nie X; Wang Z; Liu H; Zhao Y
Cancer Immunol Res; 2019 Mar; 7(3):487-497. PubMed ID: 30651289
[TBL] [Abstract][Full Text] [Related]
34. Circular RNA circ-VANGL1 as a competing endogenous RNA contributes to bladder cancer progression by regulating miR-605-3p/VANGL1 pathway.
Zeng Z; Zhou W; Duan L; Zhang J; Lu X; Jin L; Yu Y
J Cell Physiol; 2019 Apr; 234(4):3887-3896. PubMed ID: 30146736
[TBL] [Abstract][Full Text] [Related]
35. microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3.
Li Y; Zhou T; Cheng X; Li D; Zhao M; Zheng WV
Bioengineered; 2022 Mar; 13(3):4730-4743. PubMed ID: 35184646
[TBL] [Abstract][Full Text] [Related]
36. Epidermal growth factor enhances androgen receptor‑mediated bladder cancer progression and invasion via potentiation of AR transactivation.
Hsieh TF; Chen CC; Ma WL; Chuang WM; Hung XF; Tsai YR; Lin MH; Zhang Q; Zhang C; Chang C; Shyr CR
Oncol Rep; 2013 Dec; 30(6):2917-22. PubMed ID: 24126741
[TBL] [Abstract][Full Text] [Related]
37. Upregulated LINC01088 facilitates malignant phenotypes and immune escape of colorectal cancer by regulating microRNAs/G3BP1/PD-L1 axis.
Li C; Pan B; Wang X; Liu X; Qin J; Gao T; Sun H; Pan Y; Wang S
J Cancer Res Clin Oncol; 2022 Aug; 148(8):1965-1982. PubMed ID: 35357586
[TBL] [Abstract][Full Text] [Related]
38. Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype.
Xiao Y; Sun Y; Liu G; Zhao J; Gao Y; Yeh S; Gong L; Chang C
Cancer Lett; 2019 Mar; 444():175-187. PubMed ID: 30448543
[TBL] [Abstract][Full Text] [Related]
39. Hsa_circRNA_0088036 acts as a ceRNA to promote bladder cancer progression by sponging miR-140-3p.
Yang J; Qi M; Fei X; Wang X; Wang K
Cell Death Dis; 2022 Apr; 13(4):322. PubMed ID: 35396504
[TBL] [Abstract][Full Text] [Related]
40. The circ_0004463/miR-380-3p/FOXO1 axis modulates mitochondrial respiration and bladder cancer cell apoptosis.
Wu S; Deng H; He H; Xu R; Wang Y; Zhu X; Zhang J; Zeng Q; Zhao X
Cell Cycle; 2020 Dec; 19(24):3563-3580. PubMed ID: 33283616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
